Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Account Payables: 2024-2025

Historic Change in Account Payables for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $344,000.

  • Pyxis Oncology's Change in Account Payables rose 157.14% to $344,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 134.22% up from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Change in Account Payables is $344,000, which was down 94.76% from $6.6 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Change in Account Payables peaked at $6.6 million during Q2 2025, and registered a low of -$2.0 million during Q1 2025.
  • Moreover, its 2-year median value for Change in Account Payables was -$10,000 (2024), whereas its average is $871,000.
  • The largest annual percentage gain for Pyxis Oncology's Change in Account Payables in the last 5 years was 157.14% (2025), contrasted with its biggest fall of 47.47% (2025).
  • Over the past 2 years, Pyxis Oncology's Change in Account Payables (Quarterly) stood at -$10,000 in 2024, then spiked by 157.14% to $344,000 in 2025.
  • Its Change in Account Payables was $344,000 in Q3 2025, compared to $6.6 million in Q2 2025 and -$2.0 million in Q1 2025.